Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 634c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of $6.03, $6.34 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $37.14 million versus the consensus estimate of $32.41 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
• UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'